Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARGONAUT: Direct Oral Anticoagulant vs Vitamin-K Antagonist for Intra-cardiac Thrombus
NCT05825573Phase 3Active, not recruiting
- Sponsor
- CHU Nîmes
- Start
- May 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Draxaban in intracardiac thrombus, sponsored by CHU Nîmes. Started May 2023; status: active, not recruiting.
02
Drugs
Draxaban
03
Conditions
intracardiac thrombus
Beyond the preview
Go deeper on NCT05825573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825573.